Disclaimer: PolicyJack is an independent research platform. We do not sell insurance, receive commissions, or have commercial relationships with any insurer. All data is sourced from IRDAI filings, published policy wordings, and publicly available insurer data. Verify all details on the insurer’s official website before purchase.
Insurer Profile Comparison
| Parameter | Niva Bupa (formerly Max Bupa) | Care Health (formerly Religare) |
|---|---|---|
| IRDAI License | #145 | #148 |
| Rebranded From | Max Bupa (2021) | Religare Health (2020) |
| Insurer Type | Standalone Health Insurer | Standalone Health Insurer |
| Network Hospitals | 10,000+ | 22,300+ |
| CSR FY2024 | 91.1% | 90.1% |
| Key Plans | ReAssure 2.0, Aspire, Senior First | Care Supreme, Care Plus, Care Senior |
| Signature Feature | Same-illness restore (ReAssure 2.0) | Network breadth and consumables cover |
| Claims Model | In-house | In-house |
1. The Rebranding Effect: What Actually Changed
Niva Bupa underwent its rebrand in 2021 following Max Group’s exit. The operational infrastructure, claims team, product portfolio, and IRDAI license remained unchanged. ReAssure and other Max Bupa products were carried forward. The rebrand was name-only.
Care Health underwent its rebrand in 2020 following Religare Enterprises’ exit and new ownership. Similarly, the insurer entity, products, and operational infrastructure were carried forward under the Care brand.
Both brands carry the institutional knowledge and operational history of their predecessor entities. Buyers who researched “Max Bupa” or “Religare” in earlier years are researching the same insurer under a new name.
2. Claims Settlement: Near-Equivalent — But Below Top Tier
Both insurers posted approximately 91% CSR in FY2024:
- Niva Bupa: 91.1%
- Care Health: 90.1%
The 1-percentage-point gap between them is practically insignificant. More importantly, both are 10 percentage points below the top-tier insurers (Star Health 99.1%, HDFC Ergo 98.4%). Buyers comparing these two insurers should note that both represent meaningful underperformance vs the market leaders on claim settlement.
This doesn’t make them unacceptable — 90% CSR is above the composite insurer average. But it should not be ignored, particularly for buyers who expect frequent claims.
3. Product Quality: Niva Bupa’s Clause Advantage
Niva Bupa’s signature product advantage is the same-illness restore in ReAssure 2.0. No other major insurer in India matches this feature — restore activates for the same illness, same person, with unlimited triggers per year. This is the most buyer-favourable restore clause in the market.
Care Supreme’s product advantages:
- Consumables covered as standard in base plan — Niva Bupa’s standard plans exclude consumables
- NCB up to 150% — Niva Bupa’s Booster Benefit compounds differently but the cap comparison favours Care for long-term NCB accumulation
- Same-illness restore via Plus add-on — not in base plan, but the upgrade path exists
For clause quality on the most critical features (restore, consumables), Niva Bupa and Care Supreme are differentiated rather than one clearly superior across all axes.
4. Hospital Network: Care Health’s Major Advantage
Care Health: 22,300+ hospitals — the largest network in the standalone health insurance segment. This advantage is material for:
- Buyers in Tier-2/3 cities with fewer corporate hospital options
- Families that split time between multiple cities
- Buyers seeking cashless treatment in district hospitals and local nursing homes
Niva Bupa: 10,000+ hospitals — a functional metro/Tier-1 city network, but less than half of Care’s coverage by count.
For buyers whose cashless hospital access depends on a wide network, Care Health’s advantage on this dimension is significant.
5. Booster Benefit (Niva Bupa) vs NCB (Care Health)
Niva Bupa Booster Benefit: Unused SI at year-end rolls over and adds to next year’s cover (up to 100% of base SI). A ₹10 lakh plan becomes ₹20 lakh after one claim-free year.
Care Supreme NCB: Accumulates up to 150% of base SI over claim-free years. A ₹10 lakh plan grows to ₹25 lakh at the cap. Partial reduction (not full reset) on a claim year.
The comparison depends on time horizon: Niva Bupa’s Booster compounds faster in early years; Care Supreme’s higher NCB ceiling wins over a long claim-free period (8+ years).
6. Which Insurer for Which Profile
Niva Bupa is likely better for:
- Buyers with a chronic condition where same-illness restore (ReAssure 2.0) is essential
- Metro/Tier-1 buyers where the network gap (10,000 vs 22,300) is immaterial
- Buyers who want faster SI compounding through Booster Benefit
Care Health is likely better for:
- Buyers in Tier-2/3 cities where network breadth matters
- Buyers who want consumables covered as standard in the base plan
- Long-term buyers who want NCB to compound to 150% over 8+ years
For both: The 9–10 percentage point CSR gap vs top-tier insurers (Star, HDFC Ergo) should be acknowledged. Factor claim reliability explicitly into your decision.